-
7 Blue-Chip Stocks to Buy Now: May 2024
23 May 2024 22:58 GMT
… rescheduling, thanks to its subsidiary GW Pharmaceuticals, one of the first companies …
-
Antiepileptic Drugs Market Projected to Reach USD 26.3 Billion by 2031 at 4.70% CAGR
22 May 2024 13:34 GMT
… Laboratories
• Eisai Co. Ltd.
• GlaxoSmithKline
• GW Pharmaceuticals Plc
• Johnson & Johnson
• Merck …
-
Cannabis Cultivation Market Expected to Expand at a Steady 2023-2030: Aurora Cannabis, GW Pharmaceuticals plc., Aphria
02 Jun 2023 09:33 GMT
… , Inc., ABcann Medicinals, Inc. and GW Pharmaceuticals plc.
Research Methodology
The market …
-
3 Cheap Blue-Chip Stocks to Buy Now: May 2024
17 May 2024 19:27 GMT
… trends, thanks to its subsidiary GW Pharmaceuticals, one of the first companies …
-
Global Medical Cannabis Market Report to 2028 - Players Include Canopy Growth, GW Pharmaceuticals, Aurora Cannabis and Aphria
10 Feb 2023 06:50 GMT
… .
Companies Mentioned
Canopy Growth Corporation
GW Pharmaceuticals
Aurora Cannabis Inc.
Aphria Inc … -2028---players-include-canopy-growth-gw-pharmaceuticals-aurora-cannabis-and-aphria-301743167 …
-
Medical Marijuana Market Is Going To Boom with GW Pharmaceuticals, Cara Therapeutics, Sativa
07 Feb 2023 17:31 GMT
… Sativa, Inc., Arena Pharmaceuticals, Aphria, GW Pharmaceuticals, plc, Lexaria Corp, International Consolidated … Sativa, Inc., Arena Pharmaceuticals, Aphria, GW Pharmaceuticals, plc, Lexaria Corp, International Consolidated …
-
Celadon Pharmaceuticals Plc Makes History with MHRA GMP Registration for High-THC API and Could Easily Become The Next $Billion Stock As A Direct Competitor to GW Pharmaceuticals
02 Feb 2023 17:06 GMT
… Stock Exchange AIM Market since GW Pharmaceuticals in 2001. This latest news … radar of its main competitor GW Pharmaceuticals, a company which has recently … footsteps of its main competitor GW Pharmaceuticals. Celadon has the potential to …
-
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
14 May 2024 18:02 GMT
… investments:
Jazz Pharmaceuticals JAZZ Acquired GW Pharmaceuticals, which developed Epidiolex, the first …
-
Global Medical Marijuana Market Forecast to 2028 - Featuring Aphria, Canopy Growth, CanaQuest Medical and GW Pharmaceuticals Among Others - ResearchAndMarkets.com
28 Oct 2022 14:50 GMT
… Growth Corporation
CanaQuest Medical Corporation
GW Pharmaceuticals
Organigram Holdings Inc.
VIVO Cannabis …
-
U.S. Legal Marijuana Market to Witness Strong Growth by 2030 | Canopy Growth, GW Pharmaceuticals, Aurora Cannabis
17 Oct 2022 18:08 GMT
… study are Canopy Growth Corporation, GW Pharmaceuticals, Plc., Aphria, Inc., Aurora Cannabis … Key Players: Canopy Growth Corporation, GW Pharmaceuticals, Plc., Aphria, Inc., Aurora Cannabis …